Super1 TCR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Super1 TCR-T, covering 2025-09-03 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors [Phase 1]